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Approximately 12 years ago the scientific
community acknowledged that certain syn-
thetic chemicals are capable of crossing the
placental and brain barriers and interfering
with development and function (Colborn and
Clement 1992). The chemicals mimic or
interfere with endogenous hormones and
other signaling chemicals of the endocrine
system. These chemicals, distinguished as
endocrine disruptors, bridge many chemical
classes and are an integral part of the world
economy and commerce. To date no vali-
dated or standardized screens or assays have
been developed to test chemicals for their
possible endocrine-disrupting effects.
Consequently, none of the thousands of
chemicals used today have been tested sys-
tematically for these effects for regulatory
purposes. Despite this, the list is growing of
known endocrine disruptors having a wide
range of mechanisms of action that can inter-
fere with brain development (Brucker-Davis
1998; Howdeshell 2002).
The production and use of industrial and
agricultural chemicals have increased at an
almost exponential rate for the past 50 years,
with roughly 10 new chemicals currently being
introduced each day. The U.S. Environmental
Protection Agency (U.S. EPA) estimates that
87,000 chemicals are in use today. In the
United States the plastics industry has grown
at the rate of 6–12% per year since the mid-
1940s, with annual production in the United
States reaching 85 billion pounds (> 338
pounds per person per year) in 1996. In devel-
oping countries, plastics production is expand-
ing at the rate of 40% per year (Society of the
Plastics Industry 1997). Plastics are used in
toys, cosmetics, perfumes, cleaning com-
pounds, clothing, telecommunication equip-
ment, computers, almost all household
products, high-impact sporting equipment,
and construction material from buildings to
automobiles, airplanes, and aerospace vehicles. 
Currently approximately 875 active
ingredients registered as pesticides by the
U.S. EPA have been formulated into 21,000
pesticide products, with many more new
products entering the market each month
(Short and Colborn 1999). In 1995 the
United States produced 1.3 billion pounds of
pesticide active ingredients, of which herbi-
cides (weed killers) are the most widely used.
It is estimated that herbicides cover > 14% of
the land surface of the United States. This
does not include nonfarm use for lawns, gar-
dens, golf courses, parks, roadsides, railways,
airports, forests, federal applications on gov-
ernment lands, and vast rights-of-way by
states, counties, and municipalities. More
than 60% of herbicides are documented
endocrine disruptors (Short and Colborn
1999). Among the most widely used herbi-
cides that interfere with the thyroid system
are 2,4-dichlorophenoxyacetic acid (2,4-D),
acetochlor, aminotriazole, amitrole, bro-
macil, bromoxynil, pendamethalin, and the
thioureas (Brucker-Davis 1998; Howdeshell
2002; Short and Colborn 1999). 
Historical Perspective of
Exposure and Human Disorders 
When data on the growth in synthetic
chemical production are compared with the
data on increasing prevalence of neurodevel-
opmental and other developmental disorders
in humans, the data begin to merge around
1970. At approximately the same time, the
first generation of humans exposed in the
womb to synthetic chemicals on a large scale
began to have children of their own
(Table 1). For example, a plastic monomer,
bisphenol A (BPA), was introduced in the
early 1920s. Polychlorinated biphenyls
(PCBs) were introduced in 1929. DDT
became available for retail sale in 1938, and
the large-scale, widespread commercial use
of a vast number of synthetic chemicals
commenced near the end of World War II
(WWII) in the 1940s. Companies previ-
ously producing chemicals for warfare con-
verted to making pesticides and plastics as
the petroleum industry began to find more
uses for its by-products from gasoline pro-
duction. Although indivduals were being
exposed to these chemicals since the early
1920s, it was not until the end of WWII
that exposure increased to such an extent
that vast numbers of adults exposed daily
were accumulating significant amounts of
these chemicals in their bodies. In terms of
generation time, these individuals in the
1950s produced the first generation of off-
spring exposed to numerous synthetic chem-
icals in the womb and at increased levels. By
1970 these post-WWII babies were having
children of their own. It was during the
1970s that what appeared to be increases in
unusual, previously rare neurodevelopmental
disorders began to catch the attention of
health professionals.
Terms such as learning disabilities, autism,
attention deficit hyperactivity disorder
(ADHD), childhood cancers, juvenile dia-
betes, and juvenile delinquency became
household words by the mid-1990s. Parental
support groups emerged across the nation for
each anomaly, and in response, health author-
ities began to acknowledge these increases. In
1995 the U.S. EPA established the Children’s
Environmental Health Program to develop
preventive measures to protect children from
exposure to environmental contaminants, and
in 2000, a presidential initiative led to the
establishment of children’s health centers
nationwide to develop treatments and cures
for these problems. 
Gershon and Rieder (1992) provided one
of the earliest alerts that neurodevelopmental
problems were increasing in the United
States. They reported that suicides were
10-fold higher in teenagers 15–19 years of
age born in the 1950s than those born in the
1930s (Gershon and Rieder 1992). In addi-
tion the rates of depression and mania were
continuing to rise with each new birth
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Research Reviewcohort they examined. They called it a
“mystery.” They wrote that mood disorders
could arise from the interactions between
genes and “some aspects of the environ-
ment.” They implied that some individuals
were more susceptible to environmental
stresses than others because of their genetic
makeup. Although it was suggested that the
increases reﬂected better diagnoses, there was
still much discussion in the media and
among parents. Then, in 1987, Berkow and
Fletcher (1987) estimated that as many as
10% of the children < 13 years of age in the
United States suffered ADHD. A study by
Weiss et al. (1993) on children born between
1979 and 1982 found thyroid abnormalities
5 times more frequent in children with
ADHD. A study by Rowland et al. (2002)
on children born in the late 1980s and early
1990s found that 15% of the boys and 5% of
the girls from grades 1–5 in a North Carolina
countywide school district had been diag-
nosed with ADHD (p < 0.001). The study
also found that 11% of the boys and 3% of
the girls were on medication. The authors
suggested this is an underreported anomaly
because sampling depended solely on
parental responses. 
In the 1980s, occasional reports concern-
ing the increased prevalence of autism began
to appear in the peer-reviewed literature from
the United States and other countries. More
accurate clinical diagnoses and reporting of
autism occurred after the American
Psychiatric Association deﬁned this syndrome
in 1994 (American Psychiatric Association
1994). Although estimates on the prevalence
of the disorder vary widely depending on the
scope of the deﬁnition of the term, the most
recent studies consistently reveal higher preva-
lence or incidence rates (depending how the
study was designed) of both the narrow and
broad deﬁnitions. Autism disorder includes a
limited number of classic symptoms, using a
narrow set of criteria, whereas autistic spec-
trum disorder includes a broader scope of
symptoms that has been made possible in
recent years with better diagnostic tests and
technologies. A 2001 study in the United
Kingdom reported 16.8 autistic children per
10,000 using the narrow deﬁnition and 62.6
per 10,000 using the broader definition
(Chakrabarti and Fombonne 2001). A study
in 1998 of Brick Township, New Jersey,
found 40 cases per 10,000 in the narrow deﬁ-
nition group and 67 per 10,000 in the
broader definition group (Bertrand et al.
2001). This study was initiated because of
community concern about exposure to indus-
trial emissions. A 2003 study by the U.S.
Centers for Disease Control and Prevention
(CDC) (Yeargin-Allsopp et al. 2003) found
19–47 cases per 10,000 from a random sam-
pling of children in 1996 between 3 and
10 years of age from five counties in metro-
politan Atlanta, Georgia; the male–female
ratio was 4:1. As with ADHD, boys are sig-
niﬁcantly more likely to develop autism than
girls. “Autism is the fastest-growing develop-
mental disability, increasing at a rate of 10 to
17 percent annually,” according to the
Autism Society of America (Grossman 2002). 
By 1996, on the basis of extensive mag-
netic resonance imaging (MRI) and histologi-
cal examination in both humans and
laboratory animals, it became apparent that the
original autism lesion occurs just before or
shortly after neural tube closure. This is around
week 6 or 7 in the human fetus (Bayer et al.
1993; Howdeshell 2002; Rodier et al. 1996).
During this stage of development the large
cerebellar neurons begin to develop. The
increased brain weight of autistic children, the
packing of cells in the limbic system, the deﬁ-
ciency in Purkinje cells and granule cells of the
cerebellum, and a number of other differences
in the autistic brain suggest that numerous tis-
sues and stages of brain development can be
affected as the autistic syndrome evolves. In
addition one retrospective study showed that
when thalidomide exposure occurred between
gestation days 20 and 24 (week 3), approxi-
mately 30% of the phocomelia cases were also
autistic (Miller and Strömland 1993). 
Sensitivity of Neurodevelopment
to Thyroid Hormones
Although it has been known for a century that
hypothyroidism leads to retardation and other
serious developmental effects, the role of thy-
roid hormones in brain development is still not
completely understood (Rice and Barone
2000). It is also accepted that thyroid hor-
mones transferred from the mother to the
embryo and fetus are critical for normal brain
development (Lazarus 1999), even though the
thyroid gland of a fetus starts producing thy-
roid hormones at about 10 weeks (Shepard
1967) (Figure 1).
We now recognize that only a slight differ-
ence in the concentration of thyroid hormones
during pregnancy can lead to significant
changes in intelligence in children. In pregnant
women, normal thyroid hormones circulate
bound to protein at parts per billion (ppb) and
as free hormone at parts per trillion (ppt). In a
long-term study Haddow et al. (1999) col-
lected and stored blood from women in their
second trimester of pregnancy. Years later,
their children were tested between 7 and
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Figure 1. Role of thyroid hormones in fetal neurologic development in relation to timing of several landmark
stages of development. Figure adapted from Howdeshell (2002).
















Table 1. Chronology of human exposure.
Years Exposure scenario
1920s–1930s BPA, PCBs, and DDT commercially introduced. Chlorine industry expanding. Discrete postnatal 
and prenatal exposure.
1940s–WWII First wide-scale production and exposure to the above and other chemicals including plastics and 
chlorinated compounds as technology advanced.
1940s–1950s First generation widely exposed postnatally and some who may have been exposed prenatally.
1950s–1970s First generation born that was widely exposed prenatally.
1970s–1990s First generation that was widely exposed prenatally reached reproductive age.
1980s–present Second generation born that was exposed in the womb and beginning to produce the third 
generation. Production volume and exposure still increasing.9y ears of age for intelligence, attention,
language, reading ability, school performance,
and visual–motor performance. The data of
Haddow et al. revealed a possible association
between a relatively slight reduction in the
amount of circulating free thyroid hormone
levels in the mothers (2.6 ppt) and the intellec-
tual development of their children (Haddow
et al. 1999). Children of mothers with a geo-
metric mean of 9.1 ppt free thyroxine (fT4)
during gestation scored 4 points higher in IQ
than children of mothers with a geometric
mean of 7.5 ppt (p = 0.002). In this study the
thyroxine (T4) level in the lower IQ cohort
was at the low end of what is considered the
normal T4 range (Haddow et al. 1999).
Haddow et al. (1999) were not attempting to
link exposure to synthetic chemicals with loss
of intelligence in the children. However, their
results demonstrate that synthetic chemicals,
which can interfere with the thyroid system,
would not have to be present in very high con-
centrations to affect the intellectual and
behavioral development of embryos and
fetuses. Their study unexpectedly demon-
strates the fragile relationship between a
mother and her developing offspring. 
Mechanisms of Action of
Thyroid-Disrupting Chemicals
For investigators to understand the role of
endocrine disruption in brain development, it
was necessary to ﬁrst understand how thyroid
hormones regulate brain development. The
complexity of the development of both the
neurologic and thyroid systems offers numer-
ous opportunities for chemicals to interfere as
the systems develop, mature, and function.
Howdeshell (2002) provides a current road
map about the simultaneous development of
the neurologic and thyroid systems (Figure 1).
She also provides a list of those synthetic envi-
ronmental chemicals (aside from pharmaceuti-
cals and designer chemicals) known to
interfere with these systems for which mecha-
nism of action has been determined [see
Howdeshell (2002) for further list and discus-
sion]. Below is a list of demonstrated thy-
roid–pituitary disruptions that result from
environmental exposure.
• Inhibition of active transport of inorganic
iodide into the follicular cell
• Interference with the sodium/iodide trans-
porter system
• Inhibition of thyroid peroxidases to convert
inorganic iodide into organic iodide to cou-
ple iodinated tyrosyl moieties into thyroid
hormone
• Damage to follicular cells
• Inhibition or enhancement of thyroid hor-
mone release into the blood
• Inhibition or activation of the conversion of
T4 to T3 by 5´-monodeiodinase at various
sites in the body, for example, the fetal brain
• Enhancement or interference of the metabo-
lism and excretion of thyroid hormone by
liver uridine diphosphate 
• Interference with transport of thyroid hor-
mones
• Vitamin A (retinol) disturbances
• Blocking of or interfering with thyroid
receptors
Brieﬂy, there are chemicals that interfere with
iodine uptake (the herbicides 2,4-D and man-
cozeb, several PCB congeners, and thio-
cyanates) and peroxidation at the molecular
level (the herbicides aminotriazole and
thioureas, the insecticides endosulfan and
malathion, and PCBs). They also interfere
with the protein transporter that provides a
pathway for iodine to enter the cell (military
and aerospace chemicals, perchlorates).
Certain antagonists (PCBs, the herbicides
aminotriazole and dimethoate, and the insecti-
cide fenvalerate) prevent the release of thyroid
hormone from the cell and inhibit conversion
of T4 to triiodothyronine (T3). Various chem-
icals enhance excessive excretion of thyroid
hormones, some through activation of the
cytochrome P450 system (dioxin, hexa-
chlorobenzene, and fenvalerate). Some PCBs,
phthalates, and other widely used chemicals
compete for sites on the thyroid transport pro-
teins that deliver thyroid hormones through-
out the body. New research focuses on the role
of chemicals as they interfere with vitamin A
(retinols), the retinol receptors, and the essen-
tial dimerization of thyroid hormone with
retinols, a process essential for thyroid hor-
mone expression. There is still no evidence
that environmental chemicals directly block
the thyroid receptor.
For years it was thought that in humans
transthyretin (TTR) played a special role
among the thyroid transport proteins, albumin
and thyroglobulin, to transport fT4 into the
fetal brain where it is converted by the enzyme
deiodinase to free T3 (fT3) (Porterﬁeld 1994).
However, recent research using TTR knockout
mice reveals that TTR is not necessary for
transport of fT4 to the fetal murine brain
(Palha et al. 2002). Nonetheless, Brouwer et al.
(1998) pointed out that during normal enzyme
detoxification of PCBs in the maternal liver,
certain PCB congeners are hydroxylated. This
metabolic step enhances the binding afﬁnity of
the hydroxylated PCBs to TTR (Brouwer et al.
1998). Traveling on TTR in the blood, the
hydroxylated PCBs cross the placenta, enter
the fetus, and ultimately the fetal brain.
Through their high-affinity binding the
hydroxylated congeners displace essential fT4
that must get to the fetal brain to be converted
to fT3. Schuur et al. (1998) demonstrated that
the hydroxylated PCBs also interfere with the
normal excretion of thyroid hormones by
inhibiting their sulfation. PCB hydroxylates
also have estrogenic and antithyroid activity
(Iwasaki et al. 2002). For example, developing
brain cells exposed to the PCB hydroxylate
4(OH)-2´,3,3´,4´5´-pentachlorobiphenyl
(10–10 M) displayed the strongest suppression
of thyroid hormone–activated transcription
compared with any other developing cells
tested in an in vitro assay (Iwasaki et al. 2002).
This is another example of the ultrasensitivity
of brain development to PCBs. 
At the organism level, U.S. EPA scientists
were able to demonstrate the critical role of
thyroid hormones in the development of the
ear, normal hearing, and motor control. As
shown in Figure 1, the cochlea in the human
ear begins to form around 6 weeks in utero.
The cochlea is connected directly with the
brainstem, allowing for immediate transmis-
sion to and interpretation of sound in the
brain. A properly constructed cochlea is criti-
cal for hearing. Pregnant rats fed the antithy-
roid pharmaceutical propyl thiouracil had
both difﬁculty hearing low and intermediate
frequency clicking sounds and loss of motor
coordination (Goldey et al. 1995b). Another
set of pregnant rats was fed Aroclor 1254, a
commercial mixture of PCBs, which also
induced hypothyroidism and the accompany-
ing hearing and motor problems (Goldey
et al. 1995a). To conﬁrm that the PCBs inter-
fered with the thyroid system, pregnant rats
were fed Aroclor 1254 supplemented with T4,
and motor problems in the pups were attenu-
ated (Goldey and Crofton 1998). In line with
the U.S. EPA findings, Lavado-Autric et al.
(2003) report abnormal cell migration and
cytoarchitecture in the hippocampus and pri-
mary somatosensory cortex in rat pups whose
dams were fed a low-iodine diet. They point
out that the pups exhibited detectable func-
tional audio deﬁcits related to this abnormal
development (Lavado-Autric et al. 2003).
Overcoming the Difﬁculty 
of Making Causal Links 
It is almost impossible to make causal links
between prenatal contaminant exposure and
developmental damage in humans. Because of
this, scientists have used laboratory and wild-
animal models to better understand the effects
of synthetic chemicals on development.
Making a strong association between a partic-
ular chemical or class of chemicals and an
adverse condition in the ﬁeld is sometimes dif-
ﬁcult, yet in some instances an association can
be made by supplementing ﬁeld research with
well-designed laboratory research. For exam-
ple, reports of serious developmental and
reproductive problems among birds in the
North American Great Lakes and other
regions in developed countries date back to
the 1960s and early 1970s (Gilbertson 1975;
Leatherland 1992, 1999; Moccia et al. 1986).
Thyroid gland and hormone abnormalities in
particular were repeatedly reported in Great
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monitoring program to track PCBs and other
organochlorine chemicals in the lakes. In addi-
tion, Leatherland (1992) reported that every
top predator ﬁsh they examined in the Great
Lakes had enlarged thyroid glands. In the late
1990s the problem persisted as the thyroid
glands in Lake Erie fish began to rupture
because the glands were becoming so large
(Leatherland 1999), although the concentra-
tions of a number of the organochlorine
chemicals, including the PCBs, had declined
considerably in the late 1970s in the Great
Lakes. To date, no clear link has been estab-
lished with a specific chemical in the Great
Lakes that causes these thyroid problems. Lack
of iodine has been ruled out as a possible link.
Conversely, ﬁeld observations of damaged
brains and spinal cords in bald eagles and great
blue herons (Henshel et al. 1993, 1996) led to
laboratory experimentation that provided a
strong association between the anomalies and
2,3,7,8-tetrachlorodibenzo-p-dioxin, which
was discovered in elevated levels in the birds.
The laboratory results not only provided a
causal link with a contaminant but also
demonstrated the extreme sensitivity of the
developing brain to chemical interference.
Myelination is critical for proper nervous sys-
tem development, and in humans it com-
mences at approximately 12 weeks in utero
(Figure 1). Myelination was reduced in the
spinal cords of chicks exposed to dioxin (10,
100, and 1,000 ppt) in a dose–response man-
ner when injected during their egg stage.
Effects were visible and similar to the damage
seen in the wild birds at an exposure of
10 ppt, which is within the range of human
exposure (Henshel 1998; U.S. EPA 2000). 
The Human Connection
Concern in the 1970s over the widespread
health problems among Great Lakes wildlife
led to a human epidemiologic study that
examined the health effects in infants whose
mothers ate two to three meals a month of
Lake Michigan ﬁsh for at least 6 or more years
before their pregnancies (Jacobson and
Jacobson 1996). Only healthy mothers and
infants were selected for this study. Within
24 hr of birth, significant delays in neuro-
muscular and neurologic development were
detected in the children whose mothers ate the
most ﬁsh contaminated with PCBs. At 4 years
of age some children showed an association
between short-term memory problems and the
amount of PCBs in the mothers’ blood at
delivery. The same children at 11 years of age
displayed signiﬁcantly reduced academic skills
accompanied by a mean 6.2-point IQ reduc-
tion. This again was associated with their pre-
natal exposure to PCBs, not the concentration
of PCBs in their blood at the time of testing.
Although there is no way to prove that PCBs
interfered with the development of the cochlea
in these children, the affected children had dif-
ficulty with audiovisual discrimination and
information processing. Some children were as
much as 2 years behind their peers in school,
were hyperactive, and had attention problems
(Jacobson and Jacobson 1996). 
Another healthy mother–infant study
commenced 12 years later in Oswego, New
York, on Lake Ontario to replicate and expand
the design of the Lake Michigan study (Darvill
et al. 2000). As in the Lake Michigan study,
the high ﬁsh eaters consumed about the same
amount of Lake Ontario ﬁsh before their preg-
nancies (Stewart et al. 1999). Again, prenatal
exposure to PCBs was associated with neuro-
developmental changes in their children at
approximately 4 years of age. Using another
battery of tests, Stewart et al. (2000b) found
that the temperaments of the affected children
were altered compared with those of lesser-
exposed children. They smiled less, were more
fearful, and had difﬁculty adapting to changes
in their environment.
Stewart et al. (2000b) also compared the
content of the highly chlorinated PCB
homologs or isomers with 7, 8, or 9 chlorines
(septa-, octa-, and nonyl-chlorinated biphenyls)
in the mothers’ blood at the end of the first
trimester with their ﬁsh diet. The mothers who
never ate fish from the lakes had the lowest
concentrations of the highly chlorinated PCBs
in their blood. In 1984 when the ﬁrst ﬁsh advi-
sories were issued warning pregnant women
not to eat the fish from Lake Ontario, the
mothers who stopped eating ﬁsh had less of the
isomers than the mothers who only stopped
eating Lake Ontario ﬁsh when they found they
were pregnant. The mothers who did not stop
eating fish throughout their pregnancies had
the highest PCB isomer concentrations
(Stewart et al. 1999). Stewart et al. (2000a)
found a dose–response relationship between
the prenatal exposure of the children to the
highly chlorinated PCBs and increases in their
reflexive and autonomic deviations from the
norm and their reduced ability to habituate
under various conditions. MRI examination of
the most highly exposed children in this study
revealed an inverse dose–response association
between their PCB cord blood and the vol-
ume/size of the splenium of the corpus callo-
sum at 7.8 years of age, and their response
inhibition at 4.5 years of age, a behavioral
characteristic seen in ADHD children where
they do not adapt well to their environment
and have trouble settling down (Stewart et al.
2003). The splenium is the bridge between the
right and left sides of the corpus callosum.
Another set of studies with healthy
mothers and infants performed in the
Netherlands examined a cross-section of the
population, not just fish eaters (Koopman-
Esseboom et al. 1996). This team found
neuromuscular delays in the children at
3 months of age in association with in utero
exposure to PCBs and dioxins measured
as dioxin toxicity equivalents (TEQs)
(Brouwer et al. 1995). Additionally, an inverse
dose–response association was observed
between increased TEQs with thyroid levels in
the children and a positive association with
unusual changes in their immune system
(Weisglas-Kuperus et al. 1995). Further com-
parisons are difﬁcult because the same battery
of tests as those used in the United States was
not employed in this series of studies.
The Netherlands research team divided
the mothers into two groups, low TEQ
(< 30.74 pg/g fat) and high TEQ (> 30.75 pg/g
fat), on the basis of the equivalents in the
plasma of the mother during the last month of
pregnancy (Koopman-Esseboom et al. 1994).
The differences between the two cohorts in
total T4 (177.5–159.9 nmol/L) and thyroid-
stimulating hormone (TSH) (1.9–2.6 µIU/mL)
were significant at 2 weeks of age. However,
the TSH levels of the mothers were within the
normal range (3.0 IU/mL is the cutoff). 
All the effects reported in the children in
the studies described above were linked to the
children’s prenatal experience. In each study
mentioned, even though the decrements
among the children were statistically signifi-
cant at the population level, the parents or
doctors of the infants would not have known
they were compromised. It took skilled psy-
chologists and technicians to quantify the
changes in the children.
In the Lake Michigan study trained
psychologists were able to measure develop-
mental delays in infants shortly after birth if
the blood fat of the mother held 1.00 parts per
million (ppm) PCBs (Jacobson and Jacobson
1996). At 1.25 ppm PCBs, the change was sta-
tistically signiﬁcant (p < 0.001) because there
was so little variance. The intelligence and
behavioral impairments reported in this study
are populationwide. They are not rare events
such as cancer. In this healthy mother–infant
study, at 11 years of age, 11% of the children
were affected (Jacobson and Jacobson 1996).
At 4 years of age, 17 children were removed
from the study because they were too hyperac-
tive and would not take the tests (Jacobson
et al. 1990). If the outliers had remained in the
study, 20% of the children would have been
affected. It was later determined that the chil-
dren who were removed from the study were
the children of the mothers with the highest
PCB concentrations in the study. Another
child was removed from the study at the end
because he or she had an IQ below 70
(Jacobson and Jacobson 1996). These
researchers noted that consuming fish is not
the only source of PCBs, but these compounds
are found in many other foods such as meats,
fatty foods, fast foods, cheeses, ice cream, and
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et al. 2001).
A Japanese group measured TEQs in
breast milk at approximately 3 months post-
partum and compared those with T3 and T4 in
blood of the infants at 1 year of age (Nagayama
et al. 1998). Only healthy mothers and
full-term infants from southern Japan were
selected for this study. There was a signiﬁcant
inverse relationship between total TEQs and
T3 and T4 of the infants (n = 40). In this
study, TSH had no association with the conta-
minants, suggesting that TSH may not be as
sensitive an end point as previously considered
without accompanying T3 and T4 measure-
ments. No behavioral results accompanied
these data. This study conﬁrms, however, the
transfer of contaminants, measured as TEQs,
from the mother to the child and a change in
the circulating thyroid hormones of the child
distinguishable at the population level.
Opening the Black Box 
of Exposure
The most difﬁcult task for epidemiologists is
to demonstrate exposure during development
in human populations. Unlike the scenario
where dioxin exposure was correlated with
brain damage in great blue herons, in most
epidemiologic studies attempting to determine
etiology, the timing, scope of chemicals
involved or range of exposure, and the actual
body burdens of the chemicals are not know-
able. Fortunately, in the past 5 years, technol-
ogy for measuring human exposure to
synthetic chemicals has advanced consider-
ably. For example, the CDC can now monitor
human blood and urine for > 116 chlorinated
and nonchlorinated chemicals and their
metabolites. These include contemporary-use
pesticides and industrial chemicals used in cos-
metics, perfumes, detergents, toys, plastics,
and ﬁre retardants—many of which are high-
production-volume chemicals widely used in
commerce (Burse et al. 1996; CDC 2003).
CDC chemists have begun to open the
black box of exposure not only for a better
picture of human organochlorine chemical
exposure but for a number of other widely
used chemicals that have not been studied as
intensely. For example, they discovered that
some metabolites of a class of chemicals called
phthalates were 9 times higher in the urine of
women between 20 and 40 years of age—
women of childbearing age—than in any
other segment of the population (Blount et al.
2000). Phthalates make plastics flexible and
soft; they are used to improve delivery systems
in perfumes, nail polish, shampoos, cosmet-
ics, and dermal and intravenous applications
of medications. They have been widely used
as inert ingredients in pesticide formulations.
Three of the phthalates, diethylhexyl phtha-
late, di(n-octyl) phthalate, and di(n-hexyl)
phthalate, are antiandrogens in laboratory
animals, producing hypospadias, cryptor-
chidism, and other male developmental disor-
ders. They also interfere with the thyroid
system (Hinton et al. 1977; Price et al. 1988).
Discussion
Increases in the prevalence of neurodevelop-
mental disorders over the past 30 years make it
imperative to reverse this trend. Because it
appears that this trend could be partly the
result of exposure to environmental contami-
nants, it is also imperative to prevent further
exposure to synthetic chemicals that are sus-
pect. Fortunately, technological improvements
in the past 10 years have broadened the scope
and sensitivity of detection for not only syn-
thetic chemicals in human tissues but also for
natural endogenous hormones. The evidence
that certain hormones operate at parts per tril-
lion and parts per billion and equivalent expo-
sure to endocrine-active chemicals is equivalent
or higher reveals the extreme vulnerability of
development to chemical perturbation. This
detection technology, combined with large-
scale epidemiologic studies, is beginning to
reveal a panorama of subtle biological differ-
ences within populations that would never be
recognized at the individual level. The work of
Haddow et al. (1999) is an example of what we
can learn by stepping back and observing what
is happening in the population. Their work
suggests that a) it is time to reassess what is
considered euthyroid; b) quantiﬁcation of T4,
fT4, T3, and fT3 is needed to determine the
thyroid hormone status of a pregnant woman;
and c) routine maternal thyroid hormone
monitoring throughout gestation should
become standard practice. 
It is important to note that increasing
numbers of children are exhibiting attention
deﬁcit disorder and ADHD-like symptoms in
the classroom, in turn placing more and more
responsibility on teachers, families, social ser-
vices, and taxpayers. A new approach for
exploring the etiology of these disorders is
needed that could include the use of more
comprehensive case histories for the entire fam-
ily. For example, the road map of brain/thy-
roid development presented by Howdeshell
(2002) provides a starting place for speciﬁcally
seeking the etiology of neurodevelopmental
disorders. A vertical dissection of Figure 1 at
various times throughout gestation cuts
through many brain development events
occurring simultaneously that are thyroid
dependent. If a chemical were to interfere with
the commencement of development of the
cochlea at 6 weeks through its antithyroid
effect, it might also affect other thyroid-sensi-
tive tissues emerging at the same time. This
might partly explain the list of irregularities or
sequelae of anomalies that ﬁt within the deﬁni-
tion of the ADHD and autism syndromes.
Overlay maps must be constructed of other
developing systems to determine where the
presence of a foreign chemical in the womb
could interfere simultaneously with the devel-
oping brain and thyroid system. Co-morbidi-
ties should begin to appear on these overlays,
for example, the relationship between autism
and hypospadias at 7–8 weeks when sexual dif-
ferentiation commences at the same time as the
development of the urogenital system and the
hippocampus. Could one or more of the
chemicals that are known antiandrogens and
antithyroidals be involved in the latter? These
junctures could be the tip of the iceberg in
terms of determining the etiology of a disorder.
To take advantage of this approach, more
extensive case histories of autistic children are
needed to determine other anomalies they are
experiencing. In addition, exposure histories
are needed of the parents of children with
obvious developmental disorders, with empha-
sis on their lifestyle and occupational exposure
before the birth of their child, not just focusing
on the early postnatal and immediate exposure
of the child.
Because it is now the rule to demand only
statistically signiﬁcant results in studies, a great
deal of insight can be lost, as was the case with
the Lake Michigan studies. It is time to reassess
how statistics are applied in health-related
studies and the conclusions used in risk analy-
ses. For example, because an average IQ deﬁcit
of 6 points is within two standard deviations of
normal, it could be dismissed as an adverse
effect. If this statistical criterion were applied, it
would exclude the most sensitive but still
responding individuals. However, when
viewed from the population level, this can have
a tremendous impact on the economy and
integrity of a society. Unfortunately, the true
robustness of the Lake Michigan PCB studies
mentioned previously is lost in the ﬁnal statisti-
cal analysis for several reasons. First, because
only the healthiest pairs of infants and mothers
were used in any of the these studies, the most
vulnerable segment of the population was
eliminated before the study started. Second, by
eliminating the outliers (n = 18), another vul-
nerable segment of the population was
removed. In so doing, the overall population
effect was artiﬁcially reduced, thus minimizing
the importance and signiﬁcance of the study
results. It is time for a thorough reassessment
of statistical applications and study designs in
long-term, large-scale epidemiologic studies to
fully assess damage in the entire population,
not only in representative subpopulations. This
would assist those concerned about etiology
and prevention. 
During the organizational stages of
gestation, responses to endocrine disruption are
unlike the typical responses in adulthood.
Consequently, testing with mature animals
misses the organizational damage from prenatal
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exposure. In addition, most traditional toxico-
logical tests use doses 1,000–1,000,000 times
that of the equivalent physiological range at
which the endocrine systems operate and well
above real-world exposure concentrations to
synthetic chemicals. The high doses used in
toxicological testing far exceed the normal
threshold or peak concentrations at which
homeostatic negative-feedback control from
the brain shuts down cellular responses.
Consequently, other nonendocrine toxic effects
might be expressed in exposed adult animals
but not the same effects if exposure had taken
place during their construction and program-
ming. Thus, in endocrine disruption, extrapo-
lating down from several high doses to
determine the lowest safe dose or no-effect dose
of a chemical will not protect the fetus.
Fortunately, many innovative and entirely new
protocols for detecting endocrine disruption are
in the early stages of being validated and stan-
dardized in dozens of countries around the
world, but unfortunately, it will take years
before many will be ready for use.
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